Two Common Compounds Show Effectiveness Against COVID-19 Virus in Early Testing
A pair of over-the-counter compounds has been found in preliminary tests to inhibit the virus that causes COVID-19, University of Florida Health researchers have found.
UF’s COVID Restore Clinic Treats Long Haulers
Dr. Irene Estores, medical director of the Integrative Medicine Program at UF leads the COVID Restore Clinic to treat long haulers. According to the WHO definition, long COVID “occurs in individuals with a history of probable or confirmed SARS-CoV-2 infection, usually 3 months from the onset of COVID-19 with symptoms that last for at least 2 months and cannot be explained by an alternative diagnosis.”
UF Health Scientists Develop Novel Method of Cryopreserving Lung Tissue for COVID-19 Research
A team of University of Florida Health researchers have developed a method to cryopreserve lung tissue at minus-184 degrees Fahrenheit that give scientists an important new tool to study how the coronavirus infects individuals.
UF Health Psychiatrist Talks About the Mental Health Challenges Posed by COVID-19
Jacqueline Hobbs, M.D., Ph.D., an associate professor in the University of Florida College of Medicine’s department of psychiatry, discusses the burden of coping with the stress caused by the upheaval of normal life and the need to pay closer attention to our mental well-being.
UF Health Expert Discusses COVID-19 Booster Shots
Michael Lauzardo, M.D., deputy director of UF’s Emerging Pathogens Institute and an associate professor in the UF College of Medicine’s department of medicine, talks about issues related to the third vaccine dose.
UF-Led Study Explores Differences in COVID-19 Severity Internationally
The U.S. Centers for Disease Control and Prevention recently awarded a $10 million grant to a team led by Rhoel Dinglasan to test why are some countries in the grip of COVID-19 while others appear less affected.
Oragenics Initiates COVID-19 Challenge Study Evaluating Multiple Formulations of Its SARS-CoV-2 Vaccine Candidate
UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, Inc. announced the initiation of a study to evaluate the immunogenicity and viral load reduction impact of its SARS-CoV-2 vaccine candidate in a hamster challenge study.
What Is the Nipah Virus and Why Is It More Deadly Than COVID-19? A Virus Expert Explains.
Officials in India are racing to contain a virus outbreak that has claimed the life of a 12-year-old boy and is deadlier than COVID-19 — the Nipah virus.
Two-Year Backlog in Biologicals Manufacturing Hinders Medical R&D, Development of New Therapies for COVID-19
One area where COVID-19 has had a substantial impact is the development and manufacturing of medicines, medical devices, and pharmaceutical products. The CDMO industry is showing enormous growth and is projected to become a $315 billion industry by 2026. However, the demand for products skyrocketed so quickly that supply has not been able to keep pace. According to Dr. Ian White, president and CSO of Neobiosis, a UF Innovate | Sid Martin Biotech resident company that focuses on the science of regenerative medicine, demand has caused a two-year backlog of desperately needed cellular and acellular products for use in research and clinical trials directed at treating the COVID-19 virus and its complications (AKA Post-COVID Syndrome).
Breast Milk of Mothers Who Received COVID-19 Vaccine Contains Antibodies That Fight Illness
The breast milk of lactating mothers vaccinated against COVID-19 contains a significant supply of antibodies that may help protect nursing infants from the illness, according to new research from the University of Florida.
